• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS1900860 沙格列汀片 Saxagliptin Tablet Chemical Drugs(4) Generic Drug 2019-12-20 齐鲁制药有限公司 QILU Pharmaceutical Co Ltd Certificate Issued 2021-03-22 view
CYHS1302231 沙格列汀片 Saxagliptin Tablet Chemical Drugs(6) Generic Drug 2014-04-25 齐鲁制药有限公司 QILU Pharmaceutical Co Ltd Certificate Issued 2016-01-28 view
CYHS1302232 沙格列汀片 Saxagliptin Tablet Chemical Drugs(6) Generic Drug 2014-04-25 齐鲁制药有限公司 QILU Pharmaceutical Co Ltd Certificate Issued 2016-01-28 view
CYHS1900861 沙格列汀片 Saxagliptin Tablet Chemical Drugs(4) Generic Drug 2019-12-20 齐鲁制药有限公司 QILU Pharmaceutical Co Ltd Certificate Issued 2021-03-22 view
JYHB1801290 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2018-11-12 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-06-28 view
JYHB2000018 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2020-01-08 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2020-02-07 view
JYHB1801269 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2018-10-25 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-10-31 view
JXHL1900085 达格列净沙格列汀片 dapagliflozin;Saxagliptin Tablet Chemical Drugs(5.1) Import Drug Application 2019-05-09 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2019-05-08 view
JYHZ2000127 沙格列汀片 Saxagliptin Tablet Chemical Drugs License Renew 2020-05-30 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2020-12-09 view
JYHB2001397 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2020-08-21 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2020-09-09 view
JYHB1801268 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2018-10-25 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-10-31 view
JYHZ2000129 沙格列汀片 Saxagliptin Tablet Chemical Drugs License Renew 2020-05-25 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2020-12-09 view
JYHB1801291 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2018-10-29 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-06-28 view
JYHB2001396 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2020-08-21 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2020-09-09 view
JYHB1801267 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2018-10-25 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-10-31 view
JYHZ2000128 沙格列汀片 Saxagliptin Tablet Chemical Drugs License Renew 2020-05-25 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2020-12-09 view
JYHB1801292 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2018-10-29 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-06-28 view
JYHZ2000126 沙格列汀片 Saxagliptin Tablet Chemical Drugs License Renew 2020-05-30 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2020-12-09 view
JYHB1801289 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2018-11-12 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-06-28 view
JYHB2000017 沙格列汀片 Saxagliptin Tablet Chemical Drugs Supplementary Application 2020-01-08 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2020-02-07 view